Efficacy and Safety of Sijunzi Decoction for Chronic Fatigue Syndrome with Spleen Deficiency Pattern: Study Protocol for a Randomized, Double-blind, Placebo-controlled Trial

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2019 Dec 7

PMID 31807568

Citations 7

Authors

Liang Dai

Wen-Jun Zhou

Miao Wang

Shi-Gao Zhou

Guang Ji

Affiliations

Soon will be listed here.

Abstract

Background: Chronic fatigue syndrome (CFS), which is characterized by severe and disabling fatigue, has become an extensively concerned medical disorder in clinical practice. Due to the unclear etiology, current treatments are symptomatic or need assistance from psychology and kinesiology. Under the immature conditions in China, many patients would seek help from traditional Chinese medicine (TCM), in which Chinese herbal medicine (CHM) is one of the main interventions. Sijunzi Decoction (SJZD) is a classical formula and has been utilized in improving fatigue symptoms for a long time. However, lack of rigorously-designed randomized controlled trial limits its application and generalization in CFS management. Hence, we design this clinical trial to assess the effectiveness and safety of SJZD for CFS.

Methods: This is a single-center, randomized, double-blind, placebo-controlled trial. Two hundred and twelve patients with CFS will be recruited from public and equally allocated to SJZD group and placebo group. Based on the general education, these two groups will receive corresponding drugs twice a day for consecutive 2 months. The follow-up period will be 1 month. The primary outcome will be the change of Chalder fatigue scoring after treatment. Secondary outcomes include the short form-36 physical function subscale (SF36-PF), spleen deficiency rating scale, quality of life and self-rated clinical global impression (CGI) scales.

Discussion: The four ingredients of SJZD are Renshen (), Baizhu (), Fulin () and Zhigancao (), which show potential to alleviate CFS on the foundation of available studies. The results of this trial will provide high-quality clinical evidence for the application of SJZD, and hope to further support a new TCM choice in CFS treatment.

Trial Registration: ISRCTN23930966 (ISRCTN registry, registered on 28th May, 2019).

Citing Articles

Clinical Efficacy and Gut Microbiota Regulating-Related Effect of Si-Jun-Zi Decoction in Postoperative Non-Small Cell Lung Cancer Patients: A Prospective Observational Study.

He Y, Qi A, Gu Y, Zhang C, Wang Y, Yang W Integr Cancer Ther. 2024; 23:15347354241237973.

PMID: 38504436 PMC: 10953039. DOI: 10.1177/15347354241237973.

Effectiveness of Chinese Herbal Medicine in Postoperative Fatigue Syndrome Following Total Joint Arthroplasty or Hip Fracture Surgery: Evidence from Randomized Controlled Trials.

Zhao J, Zhou G, Wang Z, Liang G, Wei X, Sha B Comb Chem High Throughput Screen. 2023; 27(15):2206-2215.

PMID: 38031783 PMC: 11348457. DOI: 10.2174/0113862073258802231107060433.

Ginsenoside Rg1 can reverse fatigue behavior in CFS rats by regulating EGFR and affecting Taurine and Mannose 6-phosphate metabolism.

Lei C, Chen J, Huang Z, Men Y, Qian Y, Yu M Front Pharmacol. 2023; 14:1163638.

PMID: 37101547 PMC: 10123289. DOI: 10.3389/fphar.2023.1163638.

Sijunzi decoction granules in the prevention and treatment of recurrence of colorectal adenoma: Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.

Ni W, Liu T, Liu Y, Lu L, Zhou B, Dai Y Front Pharmacol. 2023; 14:1175811.

PMID: 37089947 PMC: 10113428. DOI: 10.3389/fphar.2023.1175811.

Elucidating the anti-aging mechanism of Si Jun Zi Tang by integrating network pharmacology and experimental validation .

Yuan Y, Zhang Y, Zheng R, Yuan H, Zhou R, Jia S Aging (Albany NY). 2022; 14(9):3941-3955.

PMID: 35537009 PMC: 9134961. DOI: 10.18632/aging.204055.

References

Tian G, Wu C, Li J, Liang B, Zhang F, Fan X . Network pharmacology based investigation into the effect and mechanism of Modified Sijunzi Decoction against the subtypes of chronic atrophic gastritis. Pharmacol Res. 2019; 144:158-166. DOI: 10.1016/j.phrs.2019.04.012. View

Xiong B, Qian H . Effects of Sijunzi decoction and Yupingfeng powder on expression of janus kinase-signal transducer and activator of transcription signal pathway in the brain of spleen-deficiency model rats. J Tradit Chin Med. 2013; 33(1):78-84. DOI: 10.1016/s0254-6272(13)60105-3. View

Straus S, Tosato G, Armstrong G, Lawley T, Preble O, Henle W . Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med. 1985; 102(1):7-16. DOI: 10.7326/0003-4819-102-1-7. View

Brenu E, Staines D, Baskurt O, Ashton K, Ramos S, Christy R . Immune and hemorheological changes in chronic fatigue syndrome. J Transl Med. 2010; 8:1. PMC: 2829521. DOI: 10.1186/1479-5876-8-1. View

Janssen M, Pickard A, Golicki D, Gudex C, Niewada M, Scalone L . Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2012; 22(7):1717-27. PMC: 3764313. DOI: 10.1007/s11136-012-0322-4. View

White P, Goldsmith K, Johnson A, Potts L, Walwyn R, DeCesare J . Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. 2011; 377(9768):823-36. PMC: 3065633. DOI: 10.1016/S0140-6736(11)60096-2. View

Cairns R, Hotopf M . A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med (Lond). 2005; 55(1):20-31. DOI: 10.1093/occmed/kqi013. View

Chan A, Tetzlaff J, Gotzsche P, Altman D, Mann H, Berlin J . SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013; 346:e7586. PMC: 3541470. DOI: 10.1136/bmj.e7586. View

Bauer P, Hamr S, Duca F . Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota. Cell Mol Life Sci. 2015; 73(4):737-55. PMC: 11108299. DOI: 10.1007/s00018-015-2083-z. View

10.

Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D . Development of a fatigue scale. J Psychosom Res. 1993; 37(2):147-53. DOI: 10.1016/0022-3999(93)90081-p. View

11.

Reynolds K, Vernon S, Bouchery E, Reeves W . The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc. 2004; 2(1):4. PMC: 449736. DOI: 10.1186/1478-7547-2-4. View

12.

Clark L, Pesola F, Thomas J, Vergara-Williamson M, Beynon M, White P . Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial. Lancet. 2017; 390(10092):363-373. PMC: 5522576. DOI: 10.1016/S0140-6736(16)32589-2. View

13.

Jason L, Richman J, Rademaker A, Jordan K, Plioplys A, Taylor R . A community-based study of chronic fatigue syndrome. Arch Intern Med. 1999; 159(18):2129-37. DOI: 10.1001/archinte.159.18.2129. View

14.

Dai L, Cheng C, Tian R, Ld Zhong L, Li Y, Lyu A . Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018). Chin J Integr Med. 2018; 25(1):71-79. DOI: 10.1007/s11655-018-2999-x. View

15.

van Kuppeveld F, de Jong A, Lanke K, Verhaegh G, Melchers W, Swanink C . Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ. 2010; 340:c1018. PMC: 2829122. DOI: 10.1136/bmj.c1018. View

16.

Reyes M, Nisenbaum R, Hoaglin D, Unger E, Emmons C, Randall B . Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med. 2003; 163(13):1530-6. DOI: 10.1001/archinte.163.13.1530. View

17.

Mawle A, Nisenbaum R, Dobbins J, Gary Jr H, Stewart J, Reyes M . Seroepidemiology of chronic fatigue syndrome: a case-control study. Clin Infect Dis. 1995; 21(6):1386-9. PMC: 7197952. DOI: 10.1093/clinids/21.6.1386. View

18.

Vernon S, Reeves W . Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome. J Autoimmune Dis. 2005; 2:5. PMC: 1177983. DOI: 10.1186/1740-2557-2-5. View

19.

Whistler T, Jones J, Unger E, Vernon S . Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol. 2005; 5(1):5. PMC: 1079885. DOI: 10.1186/1472-6793-5-5. View

20.

Lorusso L, Mikhaylova S, Capelli E, Ferrari D, Ngonga G, Ricevuti G . Immunological aspects of chronic fatigue syndrome. Autoimmun Rev. 2008; 8(4):287-91. DOI: 10.1016/j.autrev.2008.08.003. View